ABSTRACT Transforming growth factor-β1 (TGF-β1) is a potent inhibitor of muscle cell proliferation and differentiation. The TGF-β1 signal is carried by Smad proteins into the cell nucleus, resulting in the regulation of the expression of key myogenic regulatory factors including MyoD and myogenin during myogenesis. However, to date, the molecular mechanism of the inhibition by Smad-mediated TGF-β1 signaling on the function of the myogenic regulatory factors has not been well understood. The present study was designed to investigate the effect of TGF-β1 on satellite cell proliferation and differentiation by a Smad3-dependent signaling pathway. A chicken line, low score normal (LSN) with reduced muscling and upregulated TGF-β1 expression, was used and compared with a normal chicken line. In LSN satellite cell cultures, both MyoD and myogenin expression was significantly decreased compared with the normal cells. Furthermore, in response to exogenous TGF-β1, the normal satellite cells had a significant decrease in both MyoD and myogenin expression, which suggests that TGF-β1 inhibited MyoD and myogenin expression, resulting in decreased satellite cell proliferation and differentiation. The expression of Smad3 and Smad7, key proteins of the Smad family, was greater in the LSN cultures than that measured in the normal culture. The addition of TGF-β1 reduced Smad3 expression, but did not affect the expression of Smad7. The reduction of Smad3 in response to TGF-β1 suggests that a negative regulatory feedback is likely involved in LSN satellite cell proliferation and differentiation. The overexpression of Smad3 inhibited both MyoD and myogenin expression in normal and LSN satellite cells. In contrast, the underexpression of Smad3 increased the expression of MyoD and myogenin in the LSN cells. However, in the normal cells, only myogenin expression was increased by Smad3 overexpression, but not MyoD. These data together suggest that LSN satellite cells are more responsive to a Smad3-dependent TGF-β1 signaling pathway than normal satellite cells, and a Smad3-independent pathway is also likely involved in the regulation of satellite cell proliferation and differentiation.
INTRODUCTION
Skeletal muscle cells are derived from mesodermal precursor cells originating from somites (Asakura et al., 2002) . During embryonic development, the presumptive myoblasts are regulated by positive and negative signals from the extracellular environment. The presumptive myoblasts migrate from the mesodermal somites to the appropriate region and become committed myoblasts. The committed myoblasts proliferate, align with each other, and fuse to form multinucleated myotubes (Chargé and Rudnicki, 2004) .
During skeletal muscle development, growth factors are involved in regulating cell proliferation and differentiation. Transforming growth factor-β1 (TGF-β1) is a multifunctional regulator of cell growth and differentiation (Roberts and Sporn, 1985) . It has been shown that TGF-β1 inhibits both myoblast proliferation and differentiation (Allen and Boxhorn, 1987) . During myoblast differentiation, a set of muscle-specific genes is induced, leading myoblasts to form multinucleated myotubes (Florini et al., 1991) . The myoblasts also require the upregulation of the muscle regulatory factors during myogenesis. Myogenic regulatory factors, including MyoD, Myf5, myogenin, and MRF4, are basic helixloop-helix transcriptional factors involved in switch-ing on the muscle cell lineage (Chargé and Rudnicki, 2004) . The myogenic regulatory factors such as MyoD and myogenin play an essential role in the activation of muscle-specific gene transcription during myogenesis (Davis et al., 1990; Schwarz et al., 1992) .
Transforming growth factor-β1 has been shown to prevent muscle cell proliferation and differentiation by inhibiting transcriptional activity of the myogenic regulatory factors, like MyoD and myogenin during myogenesis (Vaidya et al., 1989; Martin et al., 1992) . However, the molecular mechanism of the inhibition by TGF-β1 on the function of the myogenic regulatory factors has not been well understood.
The TGF-β1 signaling pathway consists of 2 general steps that are required to carry the TGF-β1 signal to the target genes. Initially, TGF-β1 binds membrane receptors, known as receptors type Ι and type ΙΙ, and assembles a receptor complex. The TGF-β1-induced receptor complex phosphorylates Smad2/3, and then Smad2/3 are associated with Smad4, assembling a Smad complex. The activated Smad complex in the nucleus is able to regulate transcription of target genes by binding to a DNA-binding cofactor (Mehra and Wrana, 2002) . During myogenesis, TGF-β1 has been shown to reduce MyoD-induced myogenesis by Smad3 (Liu et al., 2001 ). This reduction may result from the interaction of Smad3 with MyoD. It was shown that Smad3 may inhibit the association of MyoD with the E-box, a conserved DNA sequence located in regulatory regions of many muscle-specific genes (Murre et al., 1989; Davis et al., 1990) . The interruption of MyoD with the Ebox results in the inhibition of myogenic differentiation (Liu et al., 2001 ). Smad7, one of the inhibitory Smads, reduces the signaling activity of Smad2/3 by inhibiting Smad2/3 phosphorylation (Nakao et al., 1997) . However, the TGF-β1-induced signaling pathway is not completely characterized and the association of the Smads with the myogenic regulatory factors remains unclear.
Satellite cells are myogenic precursors and are important for postnatal muscle growth. Muscle satellite cells were first identified in situ by their morphological characteristics by Mauro (1961) . Muscle satellite cells are located within the basal lamina of muscle fiber, juxtaposed with the plasma membrane (Mauro, 1961) . During the period of postnatal muscle growth, satellite cells proliferate, differentiate, and fuse with adjacent muscle fibers or with other satellite cells, and then add additional nuclei to muscle fibers, ultimately leading to increased muscle mass by muscle fiber hypertrophy (Allen et al., 1979) . Transforming growth factor-β1 has been shown to regulate satellite cell proliferation and differentiation through a Smad-mediated signaling pathway. However, little is known about how this signaling pathway functions during myogenesis.
The chicken low score normal (LSN), genetic muscle weakness, was originally detected in 1977 at the University of Connecticut among F 2 progeny in an outcross of chickens with hereditary muscular dystrophy to a commercial White Leghorn stock. Velleman et al. (1993) showed that LSN birds had a loss in pectoral muscle function and an impaired ability to right themselves when repeatedly placed on their backs. Velleman and Coy (1998) have shown that LSN birds exhibit an upregulation of TGF-β1 expression. In vitro proliferation and differentiation rate of myogenic satellite cells are lower for the LSN than for the normal (Li et al., 1997) . Because TGF-β1 functions as an inhibitor of both satellite cell proliferation and differentiation (Allen and Boxhorn, 1987) , increased expression of TGF-β1 likely results in decreased proliferation and differentiation of muscle satellite cells.
Differences in muscle growth and development in the LSN and normal chickens are possibly due to the altered activities of the myogenic regulatory factors such as MyoD and myogenin regulated by the TGF-β1-dependent signaling pathway. The present study investigated how TGF-β1 regulates the expression of MyoD and myogenin during myogenesis by a Smadmediated signaling pathway using LSN as a model to compare with normal muscle development.
MATERIALS AND METHODS

Satellite Cell Culture
Satellite cells from both normal and LSN pectoralis major muscle were isolated as described by Li et al. (1997) . The satellite cells were grown in gelatin-coated 24-well cell culture plates (Greiner Bio-One, Monroe, NC) at a plating density of 15,000 cells per well. The cells were plated in Dulbecco's Modified Eagle Medium (DMEM; Invitrogen, Carlsbad, CA) containing 10% chicken serum (Invitrogen), 5% horse serum (Invitrogen), 1% antibiotic/antimycotic (Invitrogen), and 0.1% gentamicin (Invitrogen) for 24 h, and then switched to growth medium containing McCoy's 5A medium (Sigma-Aldrich, St. Louis, MO), 10% chicken serum, 5% horse serum, 1% antibiotic/antimycotic, 0.1% gentamicin, and 20 ng/mL fibroblast growth factor 2 (Pepro Tech Inc., Rocky Hill, NY; Li et al., 1997) . When the cells reached approximately 65% confluency, differentiation was induced by culturing in low-serum differentiation medium containing DMEM, 3% horse serum, 0.01 mg/ mL porcine gelatin (Sigma-Aldrich), and 1.0 mg/mL BSA (Sigma-Aldrich). Cell cultures were removed from the incubator at 72 h of proliferation and at 0, 24, 48, 72, and 96 h of differentiation. The culture medium was removed from the plates and the cells were rinsed with sterile PBS. All plates were then stored at −70°C until analysis.
To address the effect of TGF-β1 on the expression of MyoD and myogenin, exogenous TGF-β1 was added according to the method described by Velleman and McFarland (1999a) . In brief, at the initiation of differentiation, medium containing 1 ng/mL of recombinant human TGF-β1 (Pepro Tech Inc.) was administered to normal satellite cell cultures with fresh differentiation medium added at 24-h intervals for 96 h. This concen-tration was previously determined to be appropriate by Velleman and McFarland (1999a) . Control cultures were grown without TGF-β1 treatment. The cell cultures were collected every 24 h for 96 h, rinsed with PBS, air-dried, and stored at −70°C until analysis.
Total RNA Extraction and cDNA Synthesis
Total RNA was extracted from the cell cultures by using TRIzol (Invitrogen) according to the manufacturer's protocol. Reverse transcription (RT) of total RNA to a cDNA was conducted using Moloney murine leukemia virus reverse transcriptase (M-MLV; Promega, Madison, WI). In brief, an RNA-primer mix [1 μg of total RNA, 1 μL of 50 µM Oligo d(T) 20 , and nucleasefree water up to 13.5 μL] was incubated at 80°C for 3 min, followed immediately by incubation on ice. The reaction mix [5 μL of 5× first-strand buffer, 1.25 μL of 10 mM deoxynucleoside triphosphate mix, 0.5 μL of RNasin (40 U/μL), 1 μL of M-MLV (200 U/μL), and nuclease-free water up to 11.5 μL] was added to the mixture. The complete reaction mixture was incubated at 55°C for 60 min, and then heated at 90°C for 10 min for inactivation.
Real-Time Quantitative PCR
Real-time quantitative PCR was performed using the DyNAmo Hot Start SYBR Green qPCR kit (MJ Research, Reno, NV). The PCR reaction consisted of 2 μL of the RT reaction mixture diluted with 25 μL of nuclease-free water, 10 μL of 2× master mix provided by the manufacturer, 250 nM of each of the forward and reverse primers, and nuclease-free water up to 20 μL. Reaction components were assembled in low-profile multiplates (MJ Research) and sealed with Microseal B Adhesive Seals (MJ Research). Primers used in the amplification of MyoD, myogenin, Smad3, Smad7, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were designed from published sequences as listed in Table 1 . The specificity of the primers was confirmed by DNA sequence analysis of the amplified PCR product. The real-time PCR amplification was done in a DNA Engine Opticon 2 real-time system (MJ Research, Waltham, MA). For all the amplified genes, the cycling program was initiated with a hot-start step at 95°C for 15 min. The cycling program for GAPDH was 94°C for 30 s, 55°C for 30 s, and an extension at 72°C for 30 s for 34 cycles with a final elongation of 72°C for 5 min. The cycling conditions for MyoD and myogenin were denaturation at 94°C for 30 s, annealing at 58°C for 45 s, and extension at 72°C for 45 s for 34 cycles with a final elongation for 5 min at 72°C. The PCR cycling conditions for Smad3 and Smad7 were denaturation for at 94°C for 30 s, annealing at 58°C for 30 s, and extension at 72°C for 30 s for 34 cycles with a final elongation at 72°C for 5 min. Standard curves were constructed for MyoD, myogenin, Smad3, Smad7, and GAPDH with serial dilutions of the purified PCR products from each gene. The PCR products were purified by agarose gel electrophoresis using QIAquick Gel Extraction Kit (Qiagen, Valencia, CA). All the sample concentrations fell within the values of the standard curves. The amount of sample cDNA for each gene was interpolated from the corresponding standard curve. The expression of MyoD, myogenin, Smad3, and Smad7 were normalized to GAPDH expression.
Construction of the Chicken Smad3 Expression Vector and Transient Transfection into Chicken Satellite Cells
A full-length chicken Smad3 cDNA was amplified from total RNA isolated from 20-d embryonic chicken pectoralis major muscle using RT-PCR. Reverse transcription of total RNA to a cDNA was conducted as described above. The PCR primers were designed from the published chicken Smad3 sequence (GenBank accession number AY391265) to clone the full-length chicken Smad3 cDNA. The Smad3 cDNA, a 1,281-bp nucleotide fragment, was inserted into the restriction sites XhoI and XbaI of the pCMS-EGFP containing an enhanced green fluorescent gene (EGFP; Invitrogen). The forward PCR primer was 5′-ATACTCGAGAT-GTCCTCCATCCTGCCGTTC-3′, which added an XhoI restriction site (indicated in bold) to the 5′ end, and (Reverse) the reverse PCR primer was 5′-TCATCTAGATTAG-GAGACGCTGGAGCAGCG-3′, which added an XbaI restriction site (indicated in bold) to the 3′ end. The PCR reaction was performed in a 50-µL total volume reaction mixture containing 2 µL of the RT reaction, 0.2 µM of each forward and reverse primer, 5 µL of AccuPrime Pfx Reaction Mix (Invitrogen), and 1 U of Accuprime Pfx DNA Polymerase (Invitrogen). The amplification consisted of an initial denaturation at 95°C for 5 min, and 35 cycles of 30 s at 95°C, 30 s at 55°C, and 2 min at 68°C followed by 10 min at 68°C. The amplified product was gel-purified with QIAquick Gel Extraction kit. Both the amplified product and pCMS-EGFP vector were digested with 20 U of XhoI (Invitrogen) and XbaI (Qiagen) for 4 h at 37°C. Both restriction-digested Smad3 cDNA and pCMS-EGFP vector were gel-purified with QIAquick Gel Extraction kit (Qiagen). The digested Smad3 cDNA was inserted between XhoI and XbaI of pCMS-EGFP vector as described by Velleman et al. (2004) . The positive clones were grown overnight at 37°C in 5 mL of Luria-Bertani broth containing 100 µg/mL ampicillin to expand the plasmids. The plasmids were isolated using a QIAquick Miniprep kit (Qiagen), and the chicken Smad3 insert of the plasmid was confirmed by DNA sequencing.
The satellite cells were plated at a density of 15,000 cells per well in 24-well gelatin-coated plates. After a 24-h attachment period, the cells were transiently transfected with the chicken Smad3 full-length cDNA or pCMS-EGFP vector only. The satellite cell cultures were transfected using the Optifect transfection system (Invitrogen) according to the manufacturer's recommended conditions except that 1 µg of plasmid and 2.7 µL of Optifect per well were used. The cell cultures were incubated with the transfection solution for 4 h at 37°C in a 95% air/5% CO 2 incubator. The transfection solution was replaced with the growth medium. The growth medium was changed daily until 72 h post-transfection or until the cells reach 65% confluency. Cell differentiation was induced by replacing the growth medium with differentiation medium. The differentiation medium was changed daily until 96 h of differentiation.
Small Interfering RNA Preparation and Chicken Smad3 Gene Silencing
The target-specific chicken Smad3 small interfering RNA (siRNA) duplexes were designed using Invitrogen's BLOCK-iT RNAi Designer. The siRNA sequence targeting Smad3 mRNA was selected from the open reading frame of the chicken Smad3 mRNA corresponded to the start position 607 (GenBank accession number AY391265). The sense siRNA sequence was 5′-GCAGGUUCUCCAAACUUAU [dTdT]-3′ and the antisense siRNA sequence was 5′-AUAAGUUUG-GAGAACCUGC [dTdT]-3′. The negative control sense sequence was 5′-GCAUCUUAACCUCAGGUAU-3′ and the antisense sequence was 5′-AUACCUGAGGUUAA-GAUGC-3′.
To reduce Smad3 expression, chicken satellite cells were transfected with Smad3 siRNA using Lipofectamine 2000 (Invitrogen) 24 h after plating. The negative control that did not contain the siRNA of the target gene was transfected as a control for nonspecific effects on gene expression. The Smad3 siRNA was transfected according to the manufacturer's recommended conditions, except that 50 pmol of siRNA and 1 µL of Lipofectamine 2000 per well were used. The cell cultures were incubated with the transfection solution for 4 to 6 h at 37°C in a 95% air/5% CO 2 incubator. The transfection solution was removed and replaced with growth medium. The growth medium was changed daily until 72 h posttransfection. For differentiation analysis, satellite cells were transfected with Smad3 siRNA at 65% of cell confluency (as described above). After 4 to 6 h of transfection, the cell growth medium was replaced with differentiation medium. The differentiation medium was changed daily for 96 h of differentiation.
Statistical Analysis
Differences between the means of LSN and normal satellite cells, or the control and treatment, at each sampling interval for the relative mRNA expression of the target genes were evaluated for significance with Student's t-test. Differences were considered significant at P < 0.05. Each experiment was repeated at least 3 times.
RESULTS
MyoD, Myogenin, Smad3, and Smad7 mRNA Expression in Chicken Normal and LSN Satellite Cells
The expression of both MyoD and myogenin in normal and LSN satellite cells were upregulated during proliferation and early differentiation. In normal satellite cells, MyoD expression was decreased after it peaked at 24 h of differentiation, and myogenin expression was not decreased until 48 h of differentiation ( Figure 1A and 1B) . However, the expression of MyoD and myogenin in LSN satellite cells were significantly lower compared with the normal cells from 72 h of proliferation to 72 h of differentiation. Moreover, both MyoD and myogenin expression in LSN satellite cells peaked later than in the normal cells. The MyoD expression in LSN peaked at 48 h of differentiation and then decreased gradually. The myogenin expression did not peak until 72 h of differentiation in the LSN satellite cells. The expression of myogenin in LSN was greater than in the normal cells only at 96 h of differentiation.
The expression of Smad3 in the normal satellite cells was significantly lower than that in the LSN satellite cells at 24 h of differentiation and was greater only at 96 h of differentiation ( Figure 1C ). During differentiation, the expression of Smad3 in the normal satellite cells was increased and peaked at 48 h of differentiation, whereas Smad3 expression in LSN satellite cells peaked at 24 h of differentiation. The expression of Smad7 was significantly greater in the LSN satellite cells, compared with the normal cells during both proliferation and differentiation ( Figure 1D ).
Effect of TGF-β1 on the Expression of MyoD, Myogenin, Smad3, and Smad7
The expression of both MyoD and myogenin was remarkably decreased by the addition of exogenous TGF-β1 through 96 h of differentiation (Figure 2A and 2B). Smad3 expression was also significantly reduced by TGF-β1 from 24 to 96 h of differentiation, except that no difference was measured at 72 h of differentiation ( Figure 2C ). Unlike that of Smad3, the expression of Smad7 was decreased by TGF-β1 only at 72 h of differentiation, and no other difference was noted at other times between the TGF-β1 treatment and the control without TGF-β1 ( Figure 2D ).
Overexpression and Underexpression of Smad3 in Normal and LSN Satellite Cells
Overexpression of Smad3 resulted in a significant increase in the mRNA level in both normal and LSN satellite cells compared with the respective control cells ( Figure 3A) . The Smad3 siRNA reduced Smad3 mRNA expression by 83% in normal satellite cells and 65% in the LSN satellite cells, compared with the respective control cells at 48 h following the Smad3 siRNA transfection ( Figure 3B ). 
Effect of Smad3 Overexpression on MyoD and Myogenin Expression During Normal and LSN Satellite Cell Proliferation and Differentiation
In normal satellite cells, overexpression of Smad3 reduced the expression of MyoD significantly from 72 h of proliferation to 48 h of differentiation ( Figure 4A ). Myogenin expression was significantly decreased by Smad3 overexpression at 24 h and 72 h of differentiation, especially at 72 h of differentiation, at which time the normal satellite cells had a 2-fold decrease in myogenin expression by the Smad3 overexpression ( Figure  4B ). The expression of MyoD in LSN satellite cells was reduced significantly from 24 to 72 h of differentiation by the overexpression of Smad3 ( Figure 4C ). Myogenin expression showed a significant decrease from 48 to 72 h of differentiation from the Smad3 overexpression in the LSN satellite cell culture ( Figure 4D ).
Effect of Smad3 Underexpression on MyoD and Myogenin Expression During Normal and LSN Satellite Cell Proliferation and Differentiation
In normal cell cultures with the underexpression of Smad3, MyoD expression did not appear significantly different compared with the normal control cells, except at 72 h of proliferation ( Figure 5A ), whereas myogenin expression was significantly increased at 72 h of differentiation ( Figure 5B ). The LSN satellite cells had a significant increase in MyoD expression by the underexpression of Smad3 at both 24 and 48 h of differentiation, compared with the LSN control cells ( Figure  5C ). The expression of myogenin was increased at 48 h of differentiation and decreased at 72 h of differentiation by the Smad3 underexpression. However, LSN cell cultures underexpressing Smad3 did not have significantly different expression of myogenin during pro- Figure 2 . The effect of transforming growth factor-β1 (TGF-β1) on MyoD, myogenin, Smad3, and Smad7 mRNA expression during normal satellite cell proliferation (P) and differentiation (D): A) MyoD; B) myogenin; C) Smad3; and D) Smad7. *Indicates a significant difference (P < 0.05) between the control and TGF-β1 treatment at a sampling time; bars represent the standard error of the mean.
liferation and early differentiation compared with the control LSN cells ( Figure 5D ).
DISCUSSION
Myogenic satellite cells play a pivotal role in muscle hypertrophy, muscle regeneration, and postnatal muscle growth. However, the molecular mechanism underlying the regulation of satellite cells is still unclear. Transforming growth factor-β1 is known to inhibit satellite cell proliferation and differentiation through its effect on myogenic regulatory factors, MyoD and myogenin. However, to date, the TGF-β1 transduction signaling pathway involved in myogenesis is not well understood.
In the current study, the Smad3-mediated TGF-β1 signaling pathway was examined during satellite cell proliferation and differentiation, using both normal and LSN satellite cell models. A previous study by Velleman and McFarland (1999b) demonstrated that LSN satellite cells form shorter myotubes with a reduced number of myonuclei per myotube in vitro. These changes in LSN myotube morphology in vitro are associated with reduced proliferation and differentiation rates (Li et al., 1997) as well as an increased expression of TGF-β1 compared with the normal satellite cells. The data from the current study showed that both MyoD and myogenin expression in LSN satellite cells were remarkably lower than that in the normal cells. Moreover, the expression of MyoD and myogenin in LSN cells reached peak levels later than the normal cells. The LSN satellite cells have a delay in MyoD and myogenin expression compared with the normal cells. In MyoD-deficient mice, the skeletal muscle has severely impaired muscle regeneration and an almost complete absence of satellite cell proliferation (Megeney et al., 1996) . Therefore, the decreased proliferation and differentiation of LSN satellite cells are likely due to repression of both MyoD and myogenin expression.
The proliferation and differentiation of satellite cells requires an upregulation of muscle transcriptional factors and muscle-specific genes (Olson, 1990; Weintraub et al., 1991) . This process is highly regulated through mechanisms involving cell-cell, cell-extracellular matrix, and growth factor interactions. Growth factors secreted in the matrix surrounding the satellite cells can modulate the expression of myogenic regulatory factors, regulating cell proliferation and differentiation. It has been shown that TGF-β1 reduced the expression of MyoD resulting in an inhibition of satellite cell differentiation (Liu et al., 2001) . The difference in MyoD and myogenin expression between LSN and normal cells may be due to variations in TGF-β1 levels between the 2 lines. In normal satellite cell cultures, MyoD and myogenin mRNA expression are significantly decreased in response to the addition of exogenous TGF-β1, which suggests that TGF-β1 inhibits MyoD and myogenin-induced satellite cell proliferation and differentiation.
It has been demonstrated that in response to TGF-β1, phosphorylated Smad3 directly binds to MyoD, and inhibits the transcription of MyoD resulting in reduced myogenesis (Liu et al., 2001) . Compared with the normal satellite cells, the expression of Smad3 in the LSN cells was elevated during early differentiation, which may be associated with a reduction in MyoD and myo- genin expression in the LSN cells. Smad7, one of the components in the Smad-mediated transduction pathway, functions as an inhibitor of Smad3-mediated TGF-β1 signal. In response to TGF-β1, Smad7 translocates from the nucleus to cytoplasm and binds to the TGF-β1 receptor complex, leading to a shut-down in Smad3 phosphorylation and downstream regulation of target gene expression (Itóh et al., 1998) . In LSN satellite cell cultures, the expression of Smad7 was significantly increased during both cell proliferation and differentiation, compared with the normal cells. Thus, the increase in Smad7 expression may reduce the effect of TGF-β1 on satellite cell growth, which suggests that a negative regulatory feedback is likely involved in LSN satellite cell proliferation and differentiation. Interestingly, Smad3 mRNA expression was decreased in response to exogenous TGF-β1 in the normal cells compared with the control cells, whereas Smad7 expression was not affected by TGF-β1. This may suggest that a negative regulatory feedback loop mechanism could exist during normal satellite cell proliferation and differentiation, as the expression of Smad3 was reduced by the addition of exogenous TGF-β1.
The overexpression of Smad3 in the normal satellite cells reduced both MyoD and myogenin expression, which further supports that the expression of both MyoD and myogenin is likely regulated by a Smad3-mediated TGF-β1 signaling pathway. However, the underexpression of Smad3 did not have a significant effect on the expression of MyoD and myogenin. Although quantitative PCR data showed that endogenous Smad3 mRNA was reduced over 80% compared with the control, reduction of Smad3 expression did not increase MyoD and myogenin expression. This suggests that various mechanisms are likely involved in regulation of satellite cell proliferation and differentiation.
Smad proteins are known as the major transduction molecules participating in the TGF-β signaling network. However, other cellular and genetic evidence indicates the importance of non-Smad TGF-β signaling during animal growth and development (Moustakas and Heldin, 2005) . Runyan et al. (2004) showed that TGF-β1 can activate the phosphoinositide-3 kinase pathway, leading to modulation of target gene transcription. Mitogen-activated protein kinase is also involved in TGF-β1 signal transduction (Yue and Mulder, 2000) , regulating cell proliferation and apoptosis. Because the underexpression of Smad3 did not affect MyoD and myogenin expression, the transcription of MyoD and myogenin in satellite cells may be partly regulated through a Smad3-independent TGF-β1 signaling pathway in addition to the Smad3-dependent pathway.
In LSN satellite cell cultures, both MyoD and myogenin expression was decreased by the overexpression of Smad3. Unlike the normal satellite cells, the underexpression of Smad3 in the LSN satellite cells induced MyoD and myogenin expression, suggesting that LSN satellite cells were more responsive to Smad3-mediated signal transduction than the normal cells. However, other signaling pathways may be involved in the regulation of MyoD and myogenin expression during LSN satellite cell proliferation and differentiation. Myostatin, a member of the TGF-β superfamily, which shares many similarities in structure, function, and signaling pathway with TGF-β1 (Rebbapragada et al., 2003; Zhu et al., 2004) , has been shown to be a negative regulator of muscle development (McPherron et al., 1997) . In C 2 C 12 myoblasts, myostatin inhibits cell proliferation and protein synthesis (Taylor et al., 2001) . Yang et al. (2003) demonstrated that both proliferation and differentiation of chicken embryonic myoblasts were inhibited by myostatin. These data suggest that myostatin is a possible candidate for regulating satellite cell proliferation and differentiation. Myostatin functions in a manner similar to TGF-β1. Both TGF-β1 and myostatin can interact with the extracelluar matrix, modulating cellular behaviors. Decorin, an extracellular matrix proteoglycan, binds to both TGF-β1 (Schön-herr et al., 1998) and myostatin (Miura et al., 2006) regulating their activities during myogenesis. Li et al. (2006) showed that LSN satellite cells have elevated expression of both TGF-β1 and decorin. The interaction between decorin, TGF-β1, and myostatin may alter the Smad3-mediated TGF-β1 signaling pathway resulting in modified responses to TGF-β1 as observed between the normal and LSN satellite cells. Future research will focus on the mechanism of how TGF-β1 interacts with the extracellular matrix in regulating satellite cell proliferation and differentiation.
